Commentary on the clinical and preclinical dosage limits of interstitially administered magnetic fluids for therapeutic hyperthermia based on current practice and efficacy models.
about
Commentary on the clinical and preclinical dosage limits of interstitially administered magnetic fluids for therapeutic hyperthermia based on current practice and efficacy models.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Commentary on the clinical and ...... practice and efficacy models.
@en
Commentary on the clinical and ...... practice and efficacy models.
@nl
type
label
Commentary on the clinical and ...... practice and efficacy models.
@en
Commentary on the clinical and ...... practice and efficacy models.
@nl
prefLabel
Commentary on the clinical and ...... practice and efficacy models.
@en
Commentary on the clinical and ...... practice and efficacy models.
@nl
P2860
P1476
Commentary on the clinical and ...... practice and efficacy models.
@en
P2093
Paul Southern
Quentin A Pankhurst
P2860
P356
10.1080/02656736.2017.1365953
P577
2017-10-18T00:00:00Z